Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Koo HL et al. – Travelers’ diarrhea is caused by ingestion of contaminated food and water. Bacteria are the primary cause of travelers’ diarrhea. In most surveys, the most common diarrheal pathogen identified is enterotoxigenic Escherichia coli. There are several antimicrobial agents available for the treatment of travelers’ diarrhea including rifaximin which is approved in the United States for the treatment of travelers’ diarrhea due to noninvasive E. coli strains. In this review, the authors will review the most recent advances of rifaximin for the treatment and prevention of travelers’ diarrhea, with regard to its pharmacokinetics, in vitro susceptibility profile, and efficacy and safety data from clinical trials.

Related Articles

Patchy Left-Sided Colitis: Primary Eosinophilic Colitis or Paraneoplastic Syndrome
Clinical Gastroenterology and Hepatology, 10/07/09    Relevance Score: 64%

Probiotics Have Clinical, Microbiologic, and Immunologic Efficacy in Acute Infectious Diarrhea
The Pediatric Infectious Disease Journal, 11/17/09    Relevance Score: 44%

Outcomes of diarrhea management in operations Iraqi Freedom and Enduring Freedom
Travel Medicine and Infectious Disease, 10/15/09    Relevance Score: 44%

A New Mechanism for Bile Acid Diarrhea: Defective Feedback Inhibition of Bile Acid Biosynthesis
Clinical Gastroenterology and Hepatology, 11/04/09    Relevance Score: 43%

Gap junction hemichannels contribute to the generation of diarrhea during infectious enteric disease
Gut, 10/22/09    Relevance Score: 43%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address